Trial Details

COMPLETED
Basic Information
Clinical ID c4717
Identifier NCT00072839
Trial Title Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: ALX-0600|DRUG: placebo|DRUG: teduglutide 0.05|DRUG: teduglutide 0.2 mg|DRUG: Teduglutide 0.05 dose|DRUG: teduglutide 0.1 mg dose
Participant Information
Sponsor Shire
City Tucson
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2003-11-12
Primary Completion Date 2005-07-28
Completion Date 2005-07-28